Airbnb R&D increased by 8.3% to $638.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.3%, from $568.00M to $638.00M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 13.4% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $349.73M | $344.41M | $367.80M | $363.00M | $375.00M | $366.00M | $398.00M | $420.00M | $451.00M | $419.00M | $432.00M | $475.00M | $519.00M | $524.00M | $538.00M | $568.00M | $610.00M | $587.00M | $589.00M | $638.00M |
| QoQ Change | — | -1.5% | +6.8% | -1.3% | +3.3% | -2.4% | +8.7% | +5.5% | +7.4% | -7.1% | +3.1% | +10.0% | +9.3% | +1.0% | +2.7% | +5.6% | +7.4% | -3.8% | +0.3% | +8.3% |
| YoY Change | — | — | — | — | +7.2% | +6.3% | +8.2% | +15.7% | +20.3% | +14.5% | +8.5% | +13.1% | +15.1% | +25.1% | +24.5% | +19.6% | +17.5% | +12.0% | +9.5% | +12.3% |